Generation of a COL4A5 heterozygous mutation human embryonic stem cell line (WAe009-A-58) using an episomal vector-based CRISPR/Cas9 system.

Stem Cell Res

Renal Research Institution of Beijing University of Chinese Medicine, and Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing University of Chinese Medicine, Beijing ,100700 China. Electronic address:

Published: August 2021

X-linked Alport syndrome (XLAS) is the second most common inherited kidney disease which pathogenic variants related to a mutation in the COL4A5 gene encoding the type IV collagen α5 chain. Here, we have generated a COL4A5 heterozygous mutant human embryonic stem cell (hESC) line (H9-COL4A5 by an episomal vector-based CRISPR/Cas9 system. The generated H9-COL4A5 maintained a normal stem cell morphology, stably expressed pluripotent markers, and could differentiate into all three germ layers in vivo. This cell line offers an in vitro efficient platform to explore pathogenic mechanisms in XLAS and provides a cell-based disease model for drug testing.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2021.102481DOI Listing

Publication Analysis

Top Keywords

stem cell
12
col4a5 heterozygous
8
human embryonic
8
embryonic stem
8
episomal vector-based
8
vector-based crispr/cas9
8
crispr/cas9 system
8
generation col4a5
4
heterozygous mutation
4
mutation human
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!